Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24, SINUS-52 phase 3 studies

被引：0

作者：

Desrosiers, M. ^{[1
]}

Bachert, C. ^{[2
,3
]}

Hellings, P. W. ^{[4
]}

Hopkins, C. ^{[5
]}

Olze, H. ^{[6
]}

Han, J. K. ^{[7
]}

Lee, S. E. ^{[8
]}

Zhang, M. ^{[9
]}

Lu, X. ^{[9
]}

Amin, N. ^{[10
]}

Patel, N. ^{[9
]}

Graham, N. M. H. ^{[10
]}

Ruddy, M. ^{[10
]}

Staudinger, H. ^{[9
]}

Mannent, L. P. ^{[11
]}

机构：

[1] CRCHUM, Montreal, PQ, Canada

[2] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium

[3] Karolinska Inst, Stockholm, Sweden

[4] Univ Hosp Leuven, Leuven, Belgium

[5] Guys & St Thomas Hosp, London, England

[6] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany

[7] Eastern Virginia Med Sch, Norfolk, VA 23501 USA

[8] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[9] Sanofi, Bridgewater, MA USA

[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[11] Sanofi, Chilly Mazarin, France

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

PD0613

引用

页码：330 / 331

页数：2

共 42 条